medication and pregnancy evidences database http://www.InteretTherapeutique.org/grossesse/ New studies included in the knowledge base of medication and pregnancy en studies Dydrogesterone during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Zaqout et al. The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy. Pediatr Cardiol 2015; 36:1483-8Dydrogesterone during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Katalinic A et al. A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis. Reprod Biomed Online 2022; 45:365-373-.Dydrogesterone during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Katalinic A et al. No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis. Hum Reprod Open ; 2024:hoae004-.Dydrogesterone during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Su et al. Effects of maternal exposure to exogenous progesterone during pregnancy on offspring neurodevelopment. BMC Pediatr 2025; 25:772Atypical antipsychotics (Second/Third generation) during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=260Viguera et al. Risk of Major Malformations Following First-Trimester Exposure to Cariprazine: Preliminary Data From the MGH National Pregnancy Registry for Psychiatric Medications. Bipolar Disord 2026; 28:e70138Quetiapine during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=252Broe et al. Prescription Drugs in Pregnancy and Congenital Malformations: A Population-Based Safety Screening Study. Pharmacoepidemiol Drug Saf 2025; 34:e70211Atypical antipsychotics (Second/Third generation) during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=260Broe et al. Prescription Drugs in Pregnancy and Congenital Malformations: A Population-Based Safety Screening Study. Pharmacoepidemiol Drug Saf 2025; 34:e70211Risperidone Paliperidone during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=253Broe et al. Prescription Drugs in Pregnancy and Congenital Malformations: A Population-Based Safety Screening Study. Pharmacoepidemiol Drug Saf 2025; 34:e70211Olanzapine during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=251Broe et al. Prescription Drugs in Pregnancy and Congenital Malformations: A Population-Based Safety Screening Study. Pharmacoepidemiol Drug Saf 2025; 34:e70211Aripiprazole during pregnancy - New evidence available http://www.txrating.org/grossesse/viewMA.aspx?exposition=246Broe et al. Prescription Drugs in Pregnancy and Congenital Malformations: A Population-Based Safety Screening Study. Pharmacoepidemiol Drug Saf 2025; 34:e70211